| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.726 | 0.004 | 0.726 | Superoxide dismutase inhibitor | 0.193 0.126 CID_154699926 | ||
| 0.679 | 0.004 | 0.679 | P-glycoprotein inhibitor | 0.513 0.008 CID_154699926 0.405 0.016 CID_154699517 | ||
| 0.657 | 0.003 | 0.657 | Cystathionine beta-synthase inhibitor | 0.639 0.003 CID_154699926 0.392 0.005 CID_154699517 | ||
| 0.635 | 0.003 | 0.635 | Tyrosine 3 hydroxylase inhibitor | 0.198 0.139 CID_154699926 | ||
| 0.62 | 0.01 | 0.782 | Antioxidant | 0.782 0.005 CID_154699926 0.726 0.005 CID_154699517 | CID_154699926 | |
| 0.615 | 0.005 | 0.912 | Monophenol monooxygenase inhibitor | 0.912 0.002 CID_154699926 0.866 0.002 CID_154699517 | CID_154699926 | |
| 0.609 | 0.008 | 0.735 | Free radical scavenger | 0.735 0.005 CID_154699926 0.652 0.006 CID_154699517 | CID_154699926 | |
| 0.579 | 0.003 | 0.663 | Neurotrophic factor enhancer | 0.633 0.003 CID_154699926 0.663 0.002 CID_154699517 | CID_154699517 | |
| 0.578 | 0.011 | 0.578 | Lipoxygenase inhibitor | 0.179 0.165 CID_154699926 | ||
| 0.56 | 0.011 | 0.769 | Hypoglycemic | 0.769 0.004 CID_154699926 0.66 0.005 CID_154699517 | CID_154699926 | |
| 0.56 | 0.017 | 0.629 | 5 Hydroxytryptamine release inhibitor | 0.629 0.008 CID_154699926 0.501 0.032 CID_154699517 | CID_154699926 | |
| 0.563 | 0.024 | 0.563 | Aldehyde oxidase inhibitor | |||
| 0.552 | 0.02 | 0.552 | 5 Hydroxytryptamine release stimulant | 0.413 0.043 CID_154699926 0.375 0.051 CID_154699517 | ||
| 0.559 | 0.03 | 0.559 | 15-Lipoxygenase inhibitor | |||
| 0.556 | 0.036 | 0.845 | Cyclophilin D inhibitor | 0.845 0.005 CID_154699926 0.715 0.013 CID_154699517 | CID_154699926 | |
| 0.52 | 0.005 | 0.804 | Amylase inhibitor | 0.804 0.002 CID_154699926 0.743 0.003 CID_154699517 | CID_154699926 | |
| 0.567 | 0.056 | 0.699 | Apoptosis agonist | 0.699 0.031 CID_154699926 0.658 0.038 CID_154699517 | CID_154699926 | |
| 0.543 | 0.038 | 0.849 | Transcription factor NF kappa B inhibitor | 0.849 0.01 CID_154699926 0.731 0.017 CID_154699517 | CID_154699926 | |
| 0.522 | 0.022 | 0.656 | Histamine release inhibitor | 0.656 0.006 CID_154699926 0.319 0.114 CID_154699517 | CID_154699926 | |
| 0.508 | 0.013 | 0.508 | Amyloid beta aggregation inhibitor | 0.359 0.032 CID_154699926 0.348 0.035 CID_154699517 | ||
| 0.502 | 0.007 | 0.772 | Melanin inhibitor | 0.758 0.003 CID_154699926 0.772 0.002 CID_154699517 | CID_154699517 | |
| 0.509 | 0.023 | 0.509 | GABA C receptor rho-3 antagonist | |||
| 0.479 | 0.005 | 0.479 | Breast cancer-resistant protein inhibitor | 0.086 0.071 CID_154699926 | ||
| 0.461 | 0.006 | 0.461 | 5 Hydroxytryptamine uptake stimulant | 0.195 0.162 CID_154699926 | ||
| 0.465 | 0.013 | 0.465 | Peroxidase inhibitor | |||
| 0.487 | 0.035 | 0.701 | Cholesterol antagonist | 0.701 0.008 CID_154699926 0.519 0.03 CID_154699517 | CID_154699926 | |
| 0.473 | 0.027 | 0.616 | Spasmolytic | 0.616 0.011 CID_154699926 0.387 0.043 CID_154699517 | CID_154699926 | |
| 0.479 | 0.036 | 0.479 | Calcium channel L-type activator | 0.266 0.188 CID_154699926 | ||
| 0.493 | 0.063 | 0.686 | Caspase 9 stimulant | 0.492 0.063 CID_154699926 0.686 0.026 CID_154699517 | CID_154699517 | |
| 0.511 | 0.083 | 0.811 | Antiinflammatory | 0.811 0.014 CID_154699926 0.628 0.046 CID_154699517 | CID_154699926 | |
| 0.443 | 0.025 | 0.443 | Interleukin antagonist | 0.249 0.062 CID_154699926 0.224 0.072 CID_154699517 | ||
| 0.432 | 0.032 | 0.432 | 12-Lipoxygenase inhibitor | |||
| 0.441 | 0.043 | 0.441 | Vasodilator, peripheral | 0.398 0.056 CID_154699926 0.223 0.151 CID_154699517 | ||
| 0.393 | 0.005 | 0.393 | 5-Lipoxygenase inhibitor | |||
| 0.405 | 0.034 | 0.615 | Vasodilator, coronary | 0.615 0.007 CID_154699926 0.436 0.026 CID_154699517 | CID_154699926 | |
| 0.391 | 0.021 | 0.391 | Transcription factor STAT inhibitor | 0.194 0.147 CID_154699926 | ||
| 0.41 | 0.042 | 0.47 | Caspase 3 stimulant | 0.42 0.038 CID_154699926 0.47 0.025 CID_154699517 | CID_154699517 | |
| 0.39 | 0.025 | 0.476 | Vasodilator | 0.476 0.014 CID_154699926 0.306 0.046 CID_154699517 | CID_154699926 | |
| 0.371 | 0.008 | 0.371 | Acetylcholinesterase inhibitor | 0.116 0.081 CID_154699926 0.106 0.095 CID_154699517 | ||
| 0.384 | 0.022 | 0.384 | Sodium/bile acid cotransporter inhibitor | 0.328 0.056 CID_154699926 0.217 0.165 CID_154699517 | ||
| 0.366 | 0.007 | 0.366 | Phospholipase A2 inhibitor | 0.328 0.01 CID_154699926 0.213 0.036 CID_154699517 | ||
| 0.39 | 0.033 | 0.461 | Hypoxia-inducible factor 1 alpha inhibitor | 0.461 0.018 CID_154699926 0.248 0.103 CID_154699517 | CID_154699926 | |
| 0.408 | 0.059 | 0.551 | Immunosuppressant | 0.551 0.02 CID_154699926 0.465 0.043 CID_154699517 | CID_154699926 | |
| 0.416 | 0.07 | 0.698 | Antibacterial | 0.698 0.009 CID_154699926 0.622 0.016 CID_154699517 | CID_154699926 | |
| 0.382 | 0.044 | 0.573 | Apoptosis antagonist | 0.573 0.013 CID_154699926 0.561 0.014 CID_154699517 | CID_154699926 | |
| 0.367 | 0.029 | 0.552 | Nitric oxide antagonist | 0.552 0.012 CID_154699926 0.531 0.014 CID_154699517 | CID_154699926 | |
| 0.35 | 0.013 | 0.451 | Lipid peroxidase inhibitor | 0.451 0.007 CID_154699926 0.359 0.012 CID_154699517 | CID_154699926 | |
| 0.362 | 0.029 | 0.362 | Transcription factor STAT3 inhibitor | 0.208 0.123 CID_154699926 | ||
| 0.337 | 0.007 | 0.337 | Interleukin 1b antagonist | 0.196 0.02 CID_154699926 0.187 0.022 CID_154699517 | ||
| 0.305 | 0.003 | 0.305 | DOPA decarboxylase inhibitor | 0.136 0.03 CID_154699926 | ||
| 0.305 | 0.006 | 0.305 | Estrogen antagonist | 0.137 0.031 CID_154699926 0.14 0.028 CID_154699517 | ||
| 0.306 | 0.01 | 0.306 | Succinate dehydrogenase inhibitor | 0.157 0.101 CID_154699926 | ||
| 0.3 | 0.011 | 0.3 | Interleukin 1 antagonist | 0.167 0.048 CID_154699926 0.148 0.059 CID_154699517 | ||
| 0.327 | 0.043 | 0.327 | Insulysin inhibitor | |||
| 0.286 | 0.004 | 0.286 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.297 | 0.019 | 0.297 | Protein-tyrosine phosphatase inhibitor | 0.253 0.03 CID_154699926 0.141 0.088 CID_154699517 | ||
| 0.292 | 0.02 | 0.292 | Cholinergic | |||
| 0.274 | 0.006 | 0.274 | Porphobilinogen synthase inhibitor | |||
| 0.331 | 0.064 | 0.331 | Calcium channel activator | |||
| 0.288 | 0.022 | 0.288 | MAO inhibitor | |||
| 0.283 | 0.02 | 0.283 | Insulin sensitizer | 0.274 0.023 CID_154699926 0.25 0.034 CID_154699517 | ||
| 0.346 | 0.089 | 0.346 | Calpain 2 inhibitor | |||
| 0.262 | 0.006 | 0.262 | Estrogen receptor beta antagonist | 0.092 0.08 CID_154699926 0.109 0.048 CID_154699517 | ||
| 0.303 | 0.051 | 0.453 | Antiamyloidogenic | 0.453 0.021 CID_154699926 0.195 0.103 CID_154699517 | CID_154699926 | |
| 0.321 | 0.071 | 0.321 | Streptokinase A inhibitor | |||
| 0.27 | 0.021 | 0.275 | Nitric-oxide synthase stimulant | 0.275 0.019 CID_154699926 0.263 0.024 CID_154699517 | CID_154699926 | |
| 0.266 | 0.019 | 0.266 | MAO A inhibitor | |||
| 0.277 | 0.031 | 0.277 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.211 0.064 CID_154699926 | ||
| 0.252 | 0.009 | 0.252 | Histidine decarboxylase inhibitor | |||
| 0.251 | 0.011 | 0.251 | Farnesoid X receptor antagonist | 0.137 0.069 CID_154699926 | ||
| 0.272 | 0.034 | 0.272 | Dual specificity phosphatase 3 inhibitor | |||
| 0.253 | 0.016 | 0.253 | Protein-tyrosine phosphatase 1B inhibitor | 0.236 0.019 CID_154699926 0.134 0.053 CID_154699517 | ||
| 0.366 | 0.129 | 0.686 | Alpha-glucosidase inhibitor | 0.686 0.036 CID_154699926 0.526 0.073 CID_154699517 | CID_154699926 | |
| 0.252 | 0.017 | 0.252 | Cholesterol synthesis inhibitor | 0.194 0.028 CID_154699926 0.11 0.075 CID_154699517 | ||
| 0.272 | 0.038 | 0.272 | Growth hormone agonist | |||
| 0.239 | 0.006 | 0.239 | Creatine kinase inhibitor | |||
| 0.24 | 0.009 | 0.24 | Potassium channel (Ca-activated) activator | |||
| 0.245 | 0.014 | 0.245 | GABA C receptor agonist | |||
| 0.264 | 0.035 | 0.264 | Dual specificity phosphatase inhibitor | |||
| 0.269 | 0.042 | 0.284 | Anesthetic general | 0.248 0.051 CID_154699926 0.284 0.037 CID_154699517 | CID_154699517 | |
| 0.233 | 0.007 | 0.233 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.074 0.057 CID_154699517 | ||
| 0.252 | 0.026 | 0.45 | Protein kinase stimulant | 0.45 0.005 CID_154699926 0.443 0.006 CID_154699517 | CID_154699926 | |
| 0.261 | 0.043 | 0.261 | RNA-directed DNA polymerase inhibitor | 0.224 0.07 CID_154699926 0.198 0.103 CID_154699517 | ||
| 0.278 | 0.062 | 0.491 | Tumour necrosis factor alpha release inhibitor | 0.491 0.015 CID_154699926 0.365 0.034 CID_154699517 | CID_154699926 | |
| 0.243 | 0.03 | 0.428 | Interferon gamma antagonist | 0.428 0.009 CID_154699926 0.372 0.012 CID_154699517 | CID_154699926 | |
| 0.265 | 0.052 | 0.265 | Calpain inhibitor | |||
| 0.237 | 0.027 | 0.237 | Bone formation stimulant | 0.172 0.045 CID_154699926 | ||
| 0.214 | 0.006 | 0.214 | Glutamate decarboxylase inhibitor | |||
| 0.224 | 0.017 | 0.224 | Interleukin 4 antagonist | 0.201 0.022 CID_154699926 0.156 0.044 CID_154699517 | ||
| 0.211 | 0.008 | 0.211 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.217 | 0.014 | 0.217 | CF transmembrane conductance regulator agonist | 0.176 0.04 CID_154699926 0.144 0.088 CID_154699517 | ||
| 0.208 | 0.007 | 0.208 | Macrophage migration inhibitory factor inhibitor | |||
| 0.217 | 0.019 | 0.217 | Arachidonic acid antagonist | 0.146 0.093 CID_154699926 | ||
| 0.228 | 0.03 | 0.228 | Phospholipase C inhibitor | 0.204 0.041 CID_154699926 0.185 0.055 CID_154699517 | ||
| 0.214 | 0.016 | 0.392 | UDP-glucose 4-epimerase inhibitor | 0.392 0.006 CID_154699926 0.307 0.01 CID_154699517 | CID_154699926 | |
| 0.255 | 0.06 | 0.255 | Pyruvate kinase inhibitor | |||
| 0.212 | 0.017 | 0.212 | Carbonic anhydrase XV inhibitor | |||
| 0.264 | 0.069 | 0.379 | Interleukin agonist | 0.379 0.022 CID_154699926 0.254 0.076 CID_154699517 | CID_154699926 | |
| 0.223 | 0.028 | 0.3 | Alpha-N-acetylglucosaminidase inhibitor | 0.3 0.016 CID_154699926 0.178 0.042 CID_154699517 | CID_154699926 | |
| 0.197 | 0.007 | 0.197 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.279 | 0.09 | 0.447 | Interleukin 2 agonist | 0.447 0.016 CID_154699926 0.407 0.025 CID_154699517 | CID_154699926 | |
| 0.202 | 0.016 | 0.202 | Carbonic anhydrase III inhibitor | 0.134 0.035 CID_154699926 | ||
| 0.199 | 0.013 | 0.298 | Photosensitizer | 0.298 0.004 CID_154699926 0.217 0.01 CID_154699517 | CID_154699926 | |
| 0.215 | 0.029 | 0.215 | Cyclooxygenase 1 inhibitor | 0.148 0.058 CID_154699926 | ||
| 0.181 | 0.007 | 0.181 | Lipase inhibitor | 0.122 0.017 CID_154699926 0.117 0.019 CID_154699517 | ||
| 0.196 | 0.023 | 0.196 | Ferrochelatase inhibitor | |||
| 0.224 | 0.053 | 0.514 | Hepatoprotectant | 0.514 0.006 CID_154699926 0.416 0.012 CID_154699517 | CID_154699926 | |
| 0.196 | 0.025 | 0.196 | MAO B inhibitor | |||
| 0.188 | 0.018 | 0.207 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.207 0.015 CID_154699926 0.092 0.063 CID_154699517 | CID_154699926 | |
| 0.181 | 0.011 | 0.181 | HIV-1 integrase (Strand Transfer) inhibitor | 0.102 0.022 CID_154699926 0.102 0.022 CID_154699517 | ||
| 0.176 | 0.007 | 0.176 | Leukotriene antagonist | 0.163 0.009 CID_154699926 0.066 0.044 CID_154699517 | ||
| 0.188 | 0.02 | 0.188 | Adenylate cyclase stimulant | 0.136 0.089 CID_154699926 0.122 0.12 CID_154699517 | ||
| 0.183 | 0.016 | 0.222 | Carbonic anhydrase XIII inhibitor | 0.222 0.011 CID_154699926 0.184 0.016 CID_154699517 | CID_154699926 | |
| 0.223 | 0.056 | 0.462 | Non-steroidal antiinflammatory agent | 0.462 0.008 CID_154699926 0.169 0.096 CID_154699517 | CID_154699926 | |
| 0.241 | 0.074 | 0.765 | Angiogenesis stimulant | 0.765 0.004 CID_154699926 0.546 0.009 CID_154699517 | CID_154699926 | |
| 0.177 | 0.011 | 0.177 | Transcription factor STAT6 inhibitor | |||
| 0.18 | 0.014 | 0.18 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.176 | 0.011 | 0.176 | HIV-1 integrase (3'-Processing) inhibitor | 0.108 0.023 CID_154699926 0.107 0.024 CID_154699517 | ||
| 0.18 | 0.015 | 0.18 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.182 | 0.018 | 0.182 | Vanilloid 1 agonist | 0.169 0.024 CID_154699926 0.157 0.032 CID_154699517 | ||
| 0.194 | 0.03 | 0.204 | DNA polymerase I inhibitor | 0.204 0.027 CID_154699926 0.179 0.035 CID_154699517 | CID_154699926 | |
| 0.179 | 0.016 | 0.179 | TRPA1 agonist | 0.124 0.054 CID_154699926 0.147 0.033 CID_154699517 | ||
| 0.184 | 0.023 | 0.316 | Xanthine oxidase inhibitor | 0.316 0.007 CID_154699926 0.316 0.007 CID_154699517 | CID_154699517 | |
| 0.233 | 0.072 | 0.377 | Cyclic AMP phosphodiesterase inhibitor | 0.377 0.02 CID_154699926 0.16 0.136 CID_154699517 | CID_154699926 | |
| 0.172 | 0.015 | 0.172 | Prolactin inhibitor | |||
| 0.187 | 0.031 | 0.24 | Aldehyde dehydrogenase inhibitor | 0.182 0.033 CID_154699926 0.24 0.02 CID_154699517 | CID_154699517 | |
| 0.18 | 0.024 | 0.18 | Falcipain 3 inhibitor | |||
| 0.165 | 0.009 | 0.165 | Glutathione S-transferase inhibitor | 0.092 0.046 CID_154699926 | ||
| 0.193 | 0.038 | 0.193 | Catenin beta inhibitor | |||
| 0.166 | 0.012 | 0.166 | Keratolytic | |||
| 0.242 | 0.089 | 0.242 | Gastrin inhibitor | |||
| 0.188 | 0.036 | 0.188 | GABA C receptor rho-2 antagonist | |||
| 0.167 | 0.015 | 0.167 | Ca2+-transporting ATPase inhibitor | 0.158 0.027 CID_154699926 0.138 0.08 CID_154699517 | ||
| 0.24 | 0.089 | 0.24 | Cardiotonic | |||
| 0.191 | 0.04 | 0.191 | Neurotensin receptor agonist | |||
| 0.159 | 0.009 | 0.159 | Interleukin 5 antagonist | 0.133 0.016 CID_154699926 0.121 0.023 CID_154699517 | ||
| 0.151 | 0.005 | 0.151 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.261 | 0.116 | 0.261 | Thyroid hormone antagonist | |||
| 0.214 | 0.07 | 0.342 | DNA methylase inhibitor | 0.342 0.018 CID_154699926 0.193 0.084 CID_154699517 | CID_154699926 | |
| 0.151 | 0.009 | 0.151 | Leukotriene synthesis inhibitor | 0.064 0.05 CID_154699926 | ||
| 0.165 | 0.023 | 0.165 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.15 | 0.008 | 0.15 | HIV-1 integrase inhibitor | 0.081 0.038 CID_154699926 0.063 0.062 CID_154699517 | ||
| 0.161 | 0.021 | 0.555 | Beta glucuronidase inhibitor | 0.555 0.003 CID_154699926 0.302 0.006 CID_154699517 | CID_154699926 | |
| 0.185 | 0.045 | 0.347 | Hexokinase inhibitor | 0.347 0.006 CID_154699926 0.198 0.036 CID_154699517 | CID_154699926 | |
| 0.175 | 0.037 | 0.175 | Toll-Like receptor 2 antagonist | 0.103 0.1 CID_154699517 | ||
| 0.146 | 0.008 | 0.146 | Bile acid receptor antagonist | 0.109 0.032 CID_154699926 | ||
| 0.176 | 0.039 | 0.176 | Anesthetic local | |||
| 0.257 | 0.121 | 0.67 | Antithrombotic | 0.67 0.01 CID_154699926 0.356 0.062 CID_154699517 | CID_154699926 | |
| 0.152 | 0.017 | 0.152 | Anabolic | 0.09 0.078 CID_154699926 0.096 0.069 CID_154699517 | ||
| 0.147 | 0.012 | 0.147 | Estrogen receptor alpha antagonist | |||
| 0.143 | 0.009 | 0.143 | GABA aminotransferase inhibitor | 0.137 0.01 CID_154699926 0.113 0.019 CID_154699517 | ||
| 0.17 | 0.036 | 0.17 | Proteasome inhibitor | |||
| 0.183 | 0.049 | 0.364 | NOS3 expression enhancer | 0.364 0.01 CID_154699926 0.344 0.012 CID_154699517 | CID_154699926 | |
| 0.144 | 0.011 | 0.144 | Alcohol oxidase inhibitor | |||
| 0.217 | 0.084 | 0.366 | Hypolipemic | 0.366 0.032 CID_154699926 0.188 0.103 CID_154699517 | CID_154699926 | |
| 0.145 | 0.012 | 0.145 | Estrogen agonist | 0.109 0.015 CID_154699926 0.085 0.021 CID_154699517 | ||
| 0.138 | 0.005 | 0.138 | Potassium channel Kv1.3 blocker | |||
| 0.137 | 0.005 | 0.137 | Estrogen-related receptor beta agonist | |||
| 0.153 | 0.023 | 0.253 | Topoisomerase II alpha inhibitor | 0.253 0.01 CID_154699926 0.209 0.014 CID_154699517 | CID_154699926 | |
| 0.139 | 0.008 | 0.139 | Purinergic P2X1 antagonist | 0.07 0.032 CID_154699926 0.077 0.027 CID_154699517 | ||
| 0.222 | 0.092 | 0.37 | DNA synthesis inhibitor | 0.37 0.026 CID_154699926 0.33 0.035 CID_154699517 | CID_154699926 | |
| 0.143 | 0.014 | 0.143 | Peroxisome proliferator-activated receptor gamma agonist | 0.091 0.034 CID_154699926 | ||
| 0.17 | 0.041 | 0.324 | Topoisomerase II inhibitor | 0.324 0.015 CID_154699926 0.246 0.025 CID_154699517 | CID_154699926 | |
| 0.149 | 0.021 | 0.149 | Alcohol dehydrogenase inhibitor | 0.136 0.026 CID_154699926 0.117 0.037 CID_154699517 | ||
| 0.139 | 0.011 | 0.139 | Amidase inhibitor | |||
| 0.135 | 0.008 | 0.135 | Estrogen receptor beta agonist | 0.082 0.014 CID_154699926 0.052 0.019 CID_154699517 | ||
| 0.17 | 0.043 | 0.17 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.142 | 0.017 | 0.142 | Histamine N-methyltransferase inhibitor | |||
| 0.196 | 0.071 | 0.312 | DNA methyltransferase I inhibitor | 0.312 0.022 CID_154699926 0.156 0.098 CID_154699517 | CID_154699926 | |
| 0.157 | 0.033 | 0.157 | Chelator | |||
| 0.158 | 0.034 | 0.158 | Aminopeptidase B inhibitor | |||
| 0.176 | 0.053 | 0.176 | Cyclooxygenase inhibitor | 0.131 0.086 CID_154699926 | ||
| 0.168 | 0.045 | 0.168 | Neurotrophic factor | 0.139 0.07 CID_154699926 0.152 0.057 CID_154699517 | ||
| 0.142 | 0.02 | 0.231 | Phosphofructokinase-1 inhibitor | 0.23 0.009 CID_154699926 0.231 0.009 CID_154699517 | CID_154699517 | |
| 0.128 | 0.006 | 0.128 | Estrogen receptor alpha agonist | 0.031 0.026 CID_154699926 0.034 0.024 CID_154699517 | ||
| 0.134 | 0.013 | 0.134 | Potassium channel large-conductance Ca-activated activator | |||
| 0.155 | 0.035 | 0.167 | Heat shock protein 70 antagonist | 0.167 0.02 CID_154699926 0.132 0.11 CID_154699517 | CID_154699926 | |
| 0.16 | 0.04 | 0.428 | Cyclooxygenase 3 inhibitor | 0.428 0.004 CID_154699926 0.175 0.03 CID_154699517 | CID_154699926 | |
| 0.134 | 0.015 | 0.134 | CDC25A inhibitor | 0.066 0.065 CID_154699926 | ||
| 0.146 | 0.032 | 0.146 | GABA C receptor antagonist | |||
| 0.125 | 0.011 | 0.125 | D-Ala-D-Ala ligase inhibitor | |||
| 0.237 | 0.127 | 0.237 | Thyroid hormone beta antagonist | |||
| 0.117 | 0.008 | 0.117 | GABA B receptor agonist | |||
| 0.166 | 0.059 | 0.166 | Heat shock protein 90 antagonist | |||
| 0.128 | 0.022 | 0.128 | Adrenaline agonist | |||
| 0.141 | 0.038 | 0.15 | Mucolytic | 0.15 0.033 CID_154699926 0.135 0.042 CID_154699517 | CID_154699926 | |
| 0.122 | 0.019 | 0.122 | Aminopeptidase I inhibitor | |||
| 0.108 | 0.006 | 0.108 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.11 | 0.009 | 0.11 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.112 | 0.013 | 0.112 | CDC25B inhibitor | |||
| 0.127 | 0.028 | 0.196 | Triose-phosphate isomerase inhibitor | 0.196 0.011 CID_154699926 0.123 0.031 CID_154699517 | CID_154699926 | |
| 0.101 | 0.004 | 0.101 | Dopamine D5 agonist | |||
| 0.121 | 0.025 | 0.121 | Ornithine decarboxylase inhibitor | 0.096 0.048 CID_154699926 0.083 0.064 CID_154699517 | ||
| 0.129 | 0.033 | 0.129 | GABA C receptor rho-1 antagonist | |||
| 0.144 | 0.048 | 0.144 | Death-associated protein kinase 1 inhibitor | |||
| 0.167 | 0.072 | 0.167 | Heat shock protein 90 alpha antagonist | |||
| 0.101 | 0.008 | 0.101 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.207 | 0.116 | 0.513 | Immunostimulant | 0.513 0.027 CID_154699926 0.434 0.041 CID_154699517 | CID_154699926 | |
| 0.099 | 0.01 | 0.166 | Leukotriene B4 antagonist | 0.166 0.004 CID_154699926 0.063 0.024 CID_154699517 | CID_154699926 | |
| 0.101 | 0.014 | 0.101 | Beta 3 adrenoreceptor antagonist | |||
| 0.128 | 0.041 | 0.373 | Mediator release inhibitor | 0.373 0.005 CID_154699926 0.127 0.042 CID_154699517 | CID_154699926 | |
| 0.132 | 0.045 | 0.132 | Caspase 3 inhibitor | |||
| 0.09 | 0.004 | 0.09 | Thyroid hormone alpha antagonist | |||
| 0.111 | 0.026 | 0.111 | Hematopoietic | |||
| 0.101 | 0.016 | 0.118 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.118 0.012 CID_154699926 | CID_154699926 | |
| 0.143 | 0.059 | 0.143 | NADPH oxidase inhibitor | 0.124 0.077 CID_154699926 | ||
| 0.108 | 0.027 | 0.108 | Myeloperoxidase inhibitor | |||
| 0.177 | 0.095 | 0.181 | Psychostimulant | 0.181 0.092 CID_154699926 | CID_154699926 | |
| 0.093 | 0.013 | 0.093 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.084 | 0.004 | 0.18 | Sodium/glucose cotransporter 2 inhibitor | 0.18 0.001 CID_154699926 0.153 0.001 CID_154699517 | CID_154699926 | |
| 0.097 | 0.017 | 0.097 | Beta adrenoreceptor antagonist | |||
| 0.112 | 0.033 | 0.112 | Carbonic anhydrase VI inhibitor | |||
| 0.1 | 0.022 | 0.1 | CC chemokine 5 receptor agonist | |||
| 0.113 | 0.036 | 0.169 | Thioredoxin inhibitor | 0.15 0.017 CID_154699926 0.169 0.012 CID_154699517 | CID_154699517 | |
| 0.122 | 0.046 | 0.122 | Butyrylcholinesterase inhibitor | |||
| 0.098 | 0.022 | 0.098 | Glycine receptor agonist | 0.081 0.038 CID_154699926 | ||
| 0.079 | 0.004 | 0.265 | Sodium/glucose cotransporter inhibitor | 0.265 0.001 CID_154699926 0.217 0.001 CID_154699517 | CID_154699926 | |
| 0.082 | 0.008 | 0.082 | Beta 2 adrenoreceptor agonist | |||
| 0.086 | 0.012 | 0.086 | Sphingosine kinase inhibitor | |||
| 0.076 | 0.003 | 0.076 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.092 | 0.02 | 0.092 | Maillard reaction inhibitor | 0.054 0.039 CID_154699926 | ||
| 0.085 | 0.013 | 0.085 | Sphingosine kinase 2 inhibitor | |||
| 0.088 | 0.017 | 0.088 | Prostaglandin F2 alpha antagonist | 0.06 0.047 CID_154699926 | ||
| 0.108 | 0.037 | 0.171 | NADH dehydrogenase inhibitor | 0.171 0.014 CID_154699926 0.106 0.038 CID_154699517 | CID_154699926 | |
| 0.086 | 0.016 | 0.086 | Fatty acid synthase inhibitor | |||
| 0.182 | 0.112 | 0.182 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.075 | 0.005 | 0.075 | Catechol O-methyltransferase inhibitor | 0.03 0.028 CID_154699517 | ||
| 0.089 | 0.02 | 0.15 | Neuraminidase (influenza) inhibitor | 0.15 0.007 CID_154699926 0.085 0.022 CID_154699517 | CID_154699926 | |
| 0.117 | 0.048 | 0.117 | Urease inhibitor | |||
| 0.115 | 0.048 | 0.115 | Bronchodilator | |||
| 0.101 | 0.034 | 0.101 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.089 | 0.022 | 0.089 | Biliverdin reductase inhibitor | |||
| 0.117 | 0.051 | 0.117 | Electron transport complex I inhibitor | |||
| 0.075 | 0.01 | 0.075 | Leukotriene C antagonist | |||
| 0.089 | 0.026 | 0.089 | MAP kinase kinase 7 inhibitor | |||
| 0.077 | 0.014 | 0.077 | Oleamide hydrolase inhibitor | |||
| 0.128 | 0.065 | 0.128 | Cathepsin H inhibitor | |||
| 0.067 | 0.005 | 0.067 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.098 | 0.035 | 0.098 | Vanilloid agonist | |||
| 0.079 | 0.019 | 0.079 | Beta 1 adrenoreceptor antagonist | |||
| 0.074 | 0.014 | 0.074 | Beta 2 adrenoreceptor antagonist | |||
| 0.081 | 0.023 | 0.124 | Aldose reductase inhibitor | 0.124 0.014 CID_154699926 0.089 0.02 CID_154699517 | CID_154699926 | |
| 0.089 | 0.032 | 0.089 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.094 | 0.037 | 0.094 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.122 | 0.066 | 0.122 | Adenylate cyclase inhibitor | |||
| 0.113 | 0.056 | 0.345 | Expectorant | 0.345 0.006 CID_154699926 0.237 0.014 CID_154699517 | CID_154699926 | |
| 0.066 | 0.01 | 0.066 | Dopamine beta hydroxylase inhibitor | |||
| 0.072 | 0.016 | 0.072 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.087 | 0.032 | 0.087 | Carbonic anhydrase VA inhibitor | |||
| 0.081 | 0.026 | 0.081 | Glutamate (mGluR7) antagonist | |||
| 0.101 | 0.047 | 0.101 | NMDA receptor antagonist | |||
| 0.134 | 0.08 | 0.152 | Mannose-6-phosphate isomerase inhibitor | 0.129 0.087 CID_154699926 0.152 0.063 CID_154699517 | CID_154699517 | |
| 0.108 | 0.055 | 0.108 | Adenylate kinase inhibitor | |||
| 0.062 | 0.009 | 0.062 | Prostacyclin antagonist | |||
| 0.079 | 0.026 | 0.122 | Neuraminidase inhibitor | 0.122 0.009 CID_154699926 0.075 0.03 CID_154699517 | CID_154699926 | |
| 0.07 | 0.017 | 0.07 | Dihydroorotate oxidase inhibitor | |||
| 0.078 | 0.026 | 0.078 | Xanthine dehydrogenase inhibitor | |||
| 0.113 | 0.061 | 0.113 | Acetylcholine release stimulant | 0.107 0.072 CID_154699926 | ||
| 0.112 | 0.06 | 0.112 | Protein kinase C gamma inhibitor | |||
| 0.099 | 0.048 | 0.099 | Androgen antagonist | |||
| 0.151 | 0.1 | 0.151 | Tumour necrosis factor antagonist | |||
| 0.105 | 0.054 | 0.105 | Sphingomyelinase inhibitor | |||
| 0.094 | 0.043 | 0.094 | Inducible nitric-oxide synthase inhibitor | |||
| 0.088 | 0.038 | 0.088 | Glutamate dehydrogenase inhibitor | |||
| 0.116 | 0.066 | 0.116 | Interleukin 8 antagonist | |||
| 0.182 | 0.132 | 0.259 | DNA damaging | 0.214 0.105 CID_154699926 0.259 0.075 CID_154699517 | CID_154699517 | |
| 0.065 | 0.016 | 0.065 | Immunoglobulin Fc receptor antagonist | |||
| 0.069 | 0.019 | 0.069 | Aconitate hydratase inhibitor | |||
| 0.067 | 0.018 | 0.067 | Prolyl endopeptidase inhibitor | 0.052 0.033 CID_154699517 | ||
| 0.103 | 0.055 | 0.103 | Nitric-oxide synthase inhibitor | |||
| 0.136 | 0.089 | 0.136 | Acetylcholine M1 receptor antagonist | |||
| 0.126 | 0.079 | 0.142 | Alkaline phosphatase inhibitor | 0.142 0.065 CID_154699926 | CID_154699926 | |
| 0.171 | 0.124 | 0.365 | Platelet antagonist | 0.365 0.034 CID_154699926 0.17 0.126 CID_154699517 | CID_154699926 | |
| 0.12 | 0.073 | 0.213 | DNA repair enzyme inhibitor | 0.213 0.007 CID_154699926 0.135 0.047 CID_154699517 | CID_154699926 | |
| 0.09 | 0.044 | 0.09 | Chymotrypsin inhibitor | |||
| 0.081 | 0.035 | 0.081 | Carbonic anhydrase V inhibitor | |||
| 0.064 | 0.018 | 0.064 | CD45 antagonist | |||
| 0.058 | 0.012 | 0.058 | Dihydropteroate synthase inhibitor | |||
| 0.073 | 0.028 | 0.073 | Argininosuccinate synthase inhibitor | |||
| 0.078 | 0.034 | 0.078 | Dopamine D1 antagonist | |||
| 0.143 | 0.1 | 0.239 | Interleukin 6 antagonist | 0.239 0.025 CID_154699926 0.187 0.049 CID_154699517 | CID_154699926 | |
| 0.082 | 0.038 | 0.082 | Prostaglandin-E synthase inhibitor | |||
| 0.074 | 0.032 | 0.074 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.053 | 0.011 | 0.053 | Glutamate (mGluR3) antagonist | |||
| 0.087 | 0.046 | 0.087 | Thioredoxin reductase inhibitor | |||
| 0.065 | 0.024 | 0.065 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.048 | 0.008 | 0.048 | Leukotriene B4 receptor 1 antagonist | 0.037 0.013 CID_154699926 | ||
| 0.099 | 0.058 | 0.099 | DNA directed RNA polymerase inhibitor | |||
| 0.06 | 0.019 | 0.075 | Glucose-6-phosphate isomerase inhibitor | 0.075 0.01 CID_154699926 0.072 0.012 CID_154699517 | CID_154699926 | |
| 0.078 | 0.037 | 0.078 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.082 | 0.042 | 0.082 | Cathepsin G inhibitor | |||
| 0.052 | 0.011 | 0.052 | Heme oxygenase inhibitor | |||
| 0.05 | 0.01 | 0.05 | Leukotriene C4 antagonist | |||
| 0.085 | 0.045 | 0.098 | Interferon agonist | 0.098 0.031 CID_154699926 0.077 0.057 CID_154699517 | CID_154699926 | |
| 0.047 | 0.007 | 0.047 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.053 | 0.014 | 0.053 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.085 | 0.046 | 0.085 | Ca(v)3.1 blocker | |||
| 0.072 | 0.033 | 0.072 | Aromatase inhibitor | |||
| 0.048 | 0.009 | 0.048 | ATP citrate lysase inhibitor | |||
| 0.186 | 0.147 | 0.186 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.052 | 0.014 | 0.052 | Beta adrenoreceptor agonist | |||
| 0.069 | 0.031 | 0.069 | Transcription factor RelA inhibitor | |||
| 0.049 | 0.01 | 0.049 | Leukotriene D4 antagonist | |||
| 0.055 | 0.017 | 0.055 | 5-Alpha-reductase inhibitor | |||
| 0.044 | 0.007 | 0.044 | Glutamate (mGluR3) agonist | |||
| 0.067 | 0.03 | 0.067 | Carbonic anhydrase VB inhibitor | |||
| 0.084 | 0.047 | 0.125 | Na+ K+ transporting ATPase inhibitor | 0.113 0.021 CID_154699926 0.125 0.014 CID_154699517 | CID_154699517 | |
| 0.051 | 0.015 | 0.051 | Sphingosine kinase 1 inhibitor | |||
| 0.059 | 0.024 | 0.059 | Vanilloid 2 antagonist | |||
| 0.096 | 0.061 | 0.096 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.046 | 0.011 | 0.046 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.071 | 0.036 | 0.071 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.043 | 0.009 | 0.043 | Estrogen-related receptor beta antagonist | |||
| 0.062 | 0.028 | 0.062 | NMDA 2A receptor antagonist | |||
| 0.038 | 0.006 | 0.038 | Prostaglandin F2 alpha agonist | |||
| 0.045 | 0.013 | 0.045 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.129 | 0.097 | 0.129 | Thiol protease inhibitor | |||
| 0.193 | 0.161 | 0.193 | Prostaglandin dehydrogenase inhibitor | |||
| 0.058 | 0.026 | 0.112 | Glucose-6-phosphate translocase inhibitor | 0.112 0.005 CID_154699926 0.098 0.006 CID_154699517 | CID_154699926 | |
| 0.046 | 0.014 | 0.046 | Glutamate (mGluR8) agonist | |||
| 0.038 | 0.007 | 0.038 | Thyroid hormone agonist | |||
| 0.07 | 0.039 | 0.07 | Glutamate (mGluR6) antagonist | |||
| 0.06 | 0.029 | 0.06 | Thromboxane A2 antagonist | |||
| 0.036 | 0.005 | 0.056 | Vanilloid 2 agonist | 0.056 0.002 CID_154699926 0.042 0.004 CID_154699517 | CID_154699926 | |
| 0.045 | 0.015 | 0.045 | Sirtuin 2 inhibitor | |||
| 0.135 | 0.106 | 0.135 | Mcl-1 antagonist | |||
| 0.036 | 0.007 | 0.036 | Estrogen-related receptor gamma antagonist | |||
| 0.07 | 0.041 | 0.07 | Potassium channel (ATP-sensitive) blocker | |||
| 0.049 | 0.021 | 0.049 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.082 | 0.054 | 0.116 | Glycine receptor antagonist | 0.116 0.021 CID_154699926 0.08 0.056 CID_154699517 | CID_154699926 | |
| 0.063 | 0.035 | 0.063 | Heat shock protein 90 beta antagonist | |||
| 0.037 | 0.01 | 0.037 | Thiazolidinedione | |||
| 0.059 | 0.033 | 0.059 | Thromboxane antagonist | |||
| 0.05 | 0.024 | 0.068 | Neuraminidase (Influenza A) inhibitor | 0.068 0.008 CID_154699926 0.045 0.031 CID_154699517 | CID_154699926 | |
| 0.058 | 0.032 | 0.058 | Epithelial sodium channel blocker | |||
| 0.03 | 0.004 | 0.03 | Estrogen-related receptor gamma agonist | |||
| 0.05 | 0.025 | 0.05 | Sphingosine 1-phosphate receptor agonist | |||
| 0.093 | 0.068 | 0.134 | Phosphodiesterase 6D inhibitor | 0.134 0.015 CID_154699926 0.107 0.041 CID_154699517 | CID_154699926 | |
| 0.049 | 0.024 | 0.049 | Oxytocin agonist | |||
| 0.05 | 0.025 | 0.05 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.044 | 0.021 | 0.044 | GABA uptake inhibitor | |||
| 0.028 | 0.005 | 0.028 | Nicotinic acid receptor 1 antagonist | |||
| 0.053 | 0.03 | 0.053 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.053 | 0.03 | 0.104 | Carbonic anhydrase XIV inhibitor | 0.104 0.01 CID_154699926 | CID_154699926 | |
| 0.097 | 0.074 | 0.176 | Toll-Like receptor 4 antagonist | 0.176 0.01 CID_154699926 0.165 0.014 CID_154699517 | CID_154699926 | |
| 0.074 | 0.051 | 0.074 | Phosphodiesterase 4D inhibitor | |||
| 0.051 | 0.03 | 0.051 | Adenosine deaminase inhibitor | |||
| 0.12 | 0.099 | 0.286 | Cell wall synthesis inhibitor | 0.286 0.011 CID_154699926 | CID_154699926 | |
| 0.053 | 0.032 | 0.053 | Sigma receptor antagonist | |||
| 0.055 | 0.034 | 0.105 | Alpha-mannosidase inhibitor | 0.105 0.006 CID_154699926 0.087 0.009 CID_154699517 | CID_154699926 | |
| 0.047 | 0.026 | 0.047 | AICAR transformylase inhibitor | |||
| 0.041 | 0.021 | 0.041 | Retinoid X receptor antagonist | |||
| 0.047 | 0.027 | 0.047 | NMDA receptor subunit 3B antagonist | |||
| 0.067 | 0.047 | 0.067 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.029 | 0.009 | 0.029 | Leukotriene B4 receptor 2 antagonist | 0.029 0.009 CID_154699926 | ||
| 0.043 | 0.024 | 0.043 | Kainate receptor agonist | |||
| 0.104 | 0.086 | 0.104 | Acetylcholine muscarinic antagonist | |||
| 0.059 | 0.041 | 0.059 | Ryanodine receptor antagonist | |||
| 0.061 | 0.044 | 0.069 | Transcription factor AP-1 inhibitor | 0.069 0.032 CID_154699926 | CID_154699926 | |
| 0.059 | 0.042 | 0.059 | Acetylcholine M3 receptor antagonist | |||
| 0.046 | 0.03 | 0.116 | Mannosidase inhibitor | 0.116 0.005 CID_154699926 0.081 0.008 CID_154699517 | CID_154699926 | |
| 0.041 | 0.025 | 0.041 | NMDA receptor subunit 3A antagonist | |||
| 0.037 | 0.021 | 0.037 | Fumarate hydratase inhibitor | |||
| 0.036 | 0.02 | 0.036 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.09 | 0.074 | 0.09 | Electrolyte absorption antagonist | |||
| 0.048 | 0.033 | 0.048 | Cholesterol esterase inhibitor | |||
| 0.089 | 0.074 | 0.089 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.055 | 0.04 | 0.055 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.028 | 0.015 | 0.028 | Nicotinic acid receptor 2 antagonist | |||
| 0.037 | 0.024 | 0.037 | Nicotinic acid receptor agonist | |||
| 0.035 | 0.022 | 0.035 | Retinoid X alpha receptor antagonist | |||
| 0.107 | 0.095 | 0.107 | Cyclooxygenase 2 inhibitor | |||
| 0.035 | 0.022 | 0.035 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.052 | 0.04 | 0.052 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.074 | 0.062 | 0.239 | Antineoplastic antibiotic | 0.239 0.015 CID_154699926 0.231 0.016 CID_154699517 | CID_154699926 | |
| 0.043 | 0.032 | 0.043 | Geranyltranstransferase inhibitor | |||
| 0.034 | 0.023 | 0.034 | Free fatty acid receptor 1 antagonist | |||
| 0.052 | 0.041 | 0.052 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.088 | 0.077 | 0.13 | Interleukin 12 antagonist | 0.13 0.021 CID_154699926 0.106 0.044 CID_154699517 | CID_154699926 | |
| 0.051 | 0.041 | 0.051 | Ribonucleotide reductase inhibitor | |||
| 0.164 | 0.155 | 0.164 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.023 | 0.014 | 0.023 | Beta 1 adrenoreceptor agonist | |||
| 0.015 | 0.006 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.02 | 0.011 | 0.033 | Antibiotic Anthracycline-like | 0.033 0.003 CID_154699926 0.021 0.009 CID_154699517 | CID_154699926 | |
| 0.022 | 0.013 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.047 | 0.039 | 0.047 | Bombesin 2 receptor antagonist | |||
| 0.018 | 0.009 | 0.018 | Thyroid hormone alpha agonist | |||
| 0.016 | 0.008 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.042 | 0.034 | 0.042 | Glutamate (mGluR4) antagonist | |||
| 0.03 | 0.022 | 0.03 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.016 | 0.009 | 0.016 | Antibiotic Tetracycline-like | |||
| 0.039 | 0.032 | 0.039 | Plasmepsin II inhibitor | |||
| 0.023 | 0.017 | 0.023 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.034 | 0.028 | 0.034 | Ceramide glucosyltransferase inhibitor | |||
| 0.029 | 0.023 | 0.029 | Prostaglandin agonist | |||
| 0.064 | 0.058 | 0.064 | NMDA 2 receptor antagonist | |||
| 0.041 | 0.036 | 0.041 | Glutamate (mGluR group III) antagonist | |||
| 0.05 | 0.045 | 0.155 | Heparanase inhibitor | 0.155 0.003 CID_154699926 0.063 0.018 CID_154699517 | CID_154699926 | |
| 0.054 | 0.049 | 0.054 | Pregnane X receptor antagonist | |||
| 0.048 | 0.043 | 0.048 | Alpha tubulin antagonist | |||
| 0.064 | 0.06 | 0.064 | Catalase inhibitor | |||
| 0.041 | 0.036 | 0.041 | Neurotensin receptor antagonist | |||
| 0.027 | 0.022 | 0.027 | Liver X receptor beta antagonist | |||
| 0.038 | 0.034 | 0.038 | Liver X receptor alpha agonist | |||
| 0.1 | 0.096 | 0.1 | Cholinergic antagonist | |||
| 0.107 | 0.104 | 0.107 | Antibacterial (Helicobacter pylori) | |||
| 0.032 | 0.029 | 0.064 | Arginase inhibitor | 0.064 0.009 CID_154699926 | CID_154699926 | |
| 0.044 | 0.041 | 0.044 | Plasminogen activator inhibitor antagonist | |||
| 0.024 | 0.021 | 0.024 | Sigma 2 receptor antagonist | |||
| 0.051 | 0.049 | 0.051 | 5 Hydroxytryptamine 7 agonist | |||
| 0.041 | 0.039 | 0.041 | Carbonic anhydrase VII inhibitor | |||
| 0.053 | 0.051 | 0.053 | Opioid delta receptor antagonist | |||
| 0.097 | 0.096 | 0.119 | Microtubule formation inhibitor | 0.119 0.062 CID_154699926 | CID_154699926 | |
| 0.051 | 0.049 | 0.051 | Cathepsin L inhibitor | |||
| 0.174 | 0.173 | 0.174 | Neuropeptide Y2 antagonist | |||
| 0.008 | 0.007 | 0.008 | Thyroid hormone beta agonist | |||
| 0.076 | 0.075 | 0.076 | Opioid antagonist | |||
| 0.081 | 0.081 | 0.141 | Uric acid excretion stimulant | 0.141 0.026 CID_154699926 | CID_154699926 | |
| 0.053 | 0.057 | 0.069 | Lipocortins synthesis agonist | 0.069 0.022 CID_154699926 0.057 0.042 CID_154699517 | CID_154699926 | |
| 0.092 | 0.099 | 0.203 | Alkylator | 0.203 0.026 CID_154699926 0.134 0.056 CID_154699517 | CID_154699926 | |
| 0.074 | 0.083 | 0.127 | Falcipain inhibitor | 0.127 0.041 CID_154699926 0.106 0.051 CID_154699517 | CID_154699926 | |
| 0.011 | 0.021 | 0.038 | Ileal bile acid transport inhibitor | 0.038 0.004 CID_154699926 | CID_154699926 | |
| 0.013 | 0.024 | 0.018 | Telomerase stimulant | 0.018 0.01 CID_154699926 0.016 0.014 CID_154699517 | CID_154699926 | |
| 0.071 | 0.082 | 0.125 | Falcipain 2 inhibitor | 0.125 0.04 CID_154699926 0.103 0.05 CID_154699517 | CID_154699926 | |
| 0.045 | 0.058 | 0.06 | Prostaglandin EP2 antagonist | 0.06 0.041 CID_154699926 | CID_154699926 | |
| 0.007 | 0.023 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 CID_154699926 | CID_154699926 | |
| 0.082 | 0.102 | 0.27 | AMP-activated protein kinase stimulant | 0.27 0.006 CID_154699926 | CID_154699926 | |
| 0.084 | 0.112 | 0.121 | Multidrug resistance-associated protein 1 inhibitor | 0.121 0.047 CID_154699926 | CID_154699926 | |
| 0.052 | 0.08 | 0.059 | Interferon inducer | 0.059 0.056 CID_154699926 | CID_154699926 | |
| 0.041 | 0.073 | 0.056 | Factor III inhibitor | 0.056 0.022 CID_154699926 | CID_154699926 | |
| 0.123 | 0.161 | 0.24 | ATPase inhibitor | 0.24 0.016 CID_154699926 0.17 0.07 CID_154699517 | CID_154699926 | |
| 0.019 | 0.059 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.013 CID_154699926 0.028 0.02 CID_154699517 | CID_154699926 | |
| 0.045 | 0.087 | 0.068 | Adenine nucleotide translocase inhibitor | 0.068 0.017 CID_154699926 | CID_154699926 | |
| 0.037 | 0.081 | 0.045 | Cytokine production stimulant | 0.045 0.043 CID_154699926 | CID_154699926 | |
| 0.098 | 0.142 | 0.202 | Diuretic | 0.202 0.044 CID_154699926 | CID_154699926 | |
| 0.064 | 0.111 | 0.238 | Topoisomerase I inhibitor | 0.238 0.019 CID_154699926 0.173 0.033 CID_154699517 | CID_154699926 | |
| 0.012 | 0.062 | 0.025 | Dopamine D1 agonist | 0.025 0.013 CID_154699926 | CID_154699926 | |
| 0.01 | 0.064 | 0.043 | Squalene synthetase inhibitor | 0.043 0.017 CID_154699926 | CID_154699926 | |
| 0.144 | 0.211 | 0.387 | Peptidyltransferase inhibitor | 0.387 0.008 CID_154699926 0.339 0.014 CID_154699517 | CID_154699926 | |
| 0.031 | 0.101 | 0.372 | Selectin antagonist | 0.372 0.004 CID_154699926 0.332 0.004 CID_154699517 | CID_154699926 | |
| 0.02 | 0.098 | 0.066 | Phosphorylase inhibitor | 0.066 0.022 CID_154699926 | CID_154699926 | |
| 0.076 | 0.164 | 0.327 | Thrombolytic | 0.327 0.02 CID_154699926 0.17 0.068 CID_154699517 | CID_154699926 | |
| 0.002 | 0.092 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CID_154699926 | CID_154699926 | |
| 0.03 | 0.129 | 0.073 | Nitric oxide donor | 0.073 0.029 CID_154699926 | CID_154699926 | |
| 0.038 | 0.148 | 0.103 | Histone deacetylase SIRT1 stimulant | 0.102 0.027 CID_154699926 0.103 0.026 CID_154699517 | CID_154699517 | |
| 0.038 | 0.148 | 0.103 | Histone deacetylase stimulant | 0.102 0.027 CID_154699926 0.103 0.026 CID_154699517 | CID_154699517 | |
| 0.011 | 0.125 | 0.061 | Protein 30S ribosomal subunit inhibitor | 0.056 0.007 CID_154699926 0.061 0.006 CID_154699517 | CID_154699517 | |
| 0.088 | 0.205 | 0.4 | Platelet adhesion inhibitor | 0.4 0.011 CID_154699926 0.23 0.056 CID_154699517 | CID_154699926 | |
| 0.087 | 0.218 | 0.34 | Hemostatic | 0.34 0.012 CID_154699926 | CID_154699926 | |
| 0.022 | 0.155 | 0.12 | Purinergic P2X2 antagonist | 0.12 0.021 CID_154699517 | CID_154699517 | |
| 0.018 | 0.182 | 0.077 | Antibiotic Aminoglycoside-like | 0.075 0.005 CID_154699926 0.077 0.005 CID_154699517 | CID_154699517 | |
| 0.051 | 0.223 | 0.138 | Transcription factor NF kappa B stimulant | 0.138 0.019 CID_154699926 0.111 0.03 CID_154699517 | CID_154699926 | |
| 0.059 | 0.249 | 0.263 | Cell adhesion inhibitor | 0.263 0.013 CID_154699926 | CID_154699926 | |
| 0.041 | 0.239 | 0.137 | Cell adhesion molecule inhibitor | 0.137 0.018 CID_154699926 | CID_154699926 | |
| 0.017 | 0.221 | 0.101 | Protein 50S ribosomal subunit inhibitor | 0.101 0.013 CID_154699926 0.1 0.013 CID_154699517 | CID_154699926 | |
| 0.112 | 0.341 | 0.248 | Antiobesity | 0.248 0.158 CID_154699926 | CID_154699926 | |
| 0.096 | 0.325 | 0.142 | CC chemokine 6 receptor antagonist | 0.142 0.036 CID_154699926 | CID_154699926 | |
| 0.014 | 0.251 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_154699926 | CID_154699926 | |
| 0.088 | 0.361 | 0.253 | Angiogenesis inhibitor | 0.253 0.121 CID_154699926 | CID_154699926 | |
| 0.005 | 0.279 | 0.327 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.327 0.002 CID_154699517 | CID_154699517 | |
| 0.028 | 0.302 | 0.108 | DNA intercalator | 0.108 0.066 CID_154699926 | CID_154699926 | |
| 0.027 | 0.321 | 0.115 | ATPase (Vacuolar H+) inhibitor | 0.115 0.024 CID_154699926 0.108 0.029 CID_154699517 | CID_154699926 | |
| 0.058 | 0.365 | 0.232 | Insulin secretagoues | 0.232 0.023 CID_154699926 | CID_154699926 | |
| 0.035 | 0.391 | 0.227 | Anticoagulant | 0.227 0.044 CID_154699926 | CID_154699926 | |
| 0.019 | 0.385 | 0.082 | Factor IXa inhibitor | 0.082 0.015 CID_154699926 | CID_154699926 | |
| 0.04 | 0.452 | 0.082 | T cell inhibitor | 0.082 0.059 CID_154699926 | CID_154699926 | |
| 0.038 | 0.658 | 0.358 | Immunomodulator | 0.358 0.057 CID_154699926 | CID_154699926 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |